Form 4: MapLight Therapeutics Director Buys Shares
Insider Transaction (Form 4)
Troy Cox, a Director of MapLight Therapeutics, Inc., purchased 15,620 shares of common stock on July 28, 2026 for $9.52 per share.
Summary
- Open-market purchase: acquired 15,620 Voting Common Stock at $9.52 ($148,702) on July 28, 2026; holds 15,620 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $148,702, committing personal capital to the stock.
Insider Transactions
Troy Cox — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Open-market purchase | Voting Common Stock | 15,620 | $10 | $148.7K | 15,620 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Open-market purchase (15,620 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bullish, Troy Cox
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.